Stimulatory effect of imeglimin on incretin secretion

AIMS/INTRODUCTION: Imeglimin is a new antidiabetic drug structurally related to metformin. Despite this structural similarity, only imeglimin augments glucose‐stimulated insulin secretion (GSIS), with the mechanism underlying this effect remaining unclear. Given that glucose‐dependent insulinotropic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yingyue, Quan, Sugawara, Kenji, Takahashi, Harumi, Yokoi, Norihide, Ohbayashi, Kento, Iwasaki, Yusaku, Seino, Susumu, Ogawa, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204172/
https://www.ncbi.nlm.nih.gov/pubmed/36977210
http://dx.doi.org/10.1111/jdi.14001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204172/
https://www.ncbi.nlm.nih.gov/pubmed/36977210
http://dx.doi.org/10.1111/jdi.14001

Ejemplares similares